🇺🇸 FDA
Patent

US 9474787

Mesenchymal stem cells for the treatment of CNS diseases

granted A61KA61K35/12A61K35/28

Quick answer

US patent 9474787 (Mesenchymal stem cells for the treatment of CNS diseases) held by BRAINSTORM CELL THERAPEUTICS LTD. expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BRAINSTORM CELL THERAPEUTICS LTD.
Grant date
Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K35/12, A61K35/28, A61K38/185, A61P